Waystar Weighs Sale Amid Market Challenges, Sources Report

Healthcare software provider Waystar is reportedly exploring strategic options, including a potential sale, according to sources familiar with the matter. This development comes as the company faces a challenging market environment, two years after its public listing in New York.

Investment Bank Evercore Advises on the Process

Waystar, based in Lehi, Utah, and Louisville, Kentucky, has engaged investment bank Evercore to advise on the possible sale process. According to sources, the discussions are at an early stage, and there is no guarantee that a sale will occur. Both Waystar and Evercore have declined to comment on the situation.

The company, which provides software to automate and manage administrative tasks for hospitals and doctors, has seen its market value decrease to approximately $4.8 billion. This drop follows a 24% decline in its share price this year, part of a broader downturn affecting the software sector.

Market Valuation and Strategic Positioning

Waystar has positioned itself as a technology company rather than a traditional healthcare services provider. This strategy aimed to attract higher valuations typically associated with tech firms. Initially, investors responded positively, driving shares from $20 to a peak of $45 in 2025. However, concerns about the impact of artificial intelligence on software companies have since put pressure on the stock, according to a July report by Morgan Stanley analysts.

Waystar was established in 2017 through the merger of healthcare revenue management companies Zirmed and Navicure. It went public in 2024, backed by major investors such as EQT, the Canada Pension Plan Investment Board (CPPIB), and Bain Capital. Currently, EQT holds a 13% stake, CPPIB owns 10%, and BlackRock Institutional Trust Company has an 8% share, as per LSEG data.

Investor Sentiment and Sector Challenges

The potential sale could test investor appetite for software firms amidst a challenging market landscape. Despite initial enthusiasm, the sector has faced skepticism due to the rapid advancement of AI technologies that could disrupt traditional software models.

As Waystar navigates these challenges, the outcome of its strategic review remains uncertain. The company must balance investor expectations and market realities as it considers its next steps.